“…Address for correspondence: g2119@ online.ru. V. E. GmiroAntagonists of the polyamine site of N-methyl-Daspartate (NMDA) receptors arcaine and ifenprodil in systemic administration are not inferior to NMDA receptor channel blockers memantine and MK-801 by their anticonvulsant activity in seizures modeled by systemic administration of NMDA and pentylenetetrazole and depending on permeability of the blood-brain barrier (BBB) [1,2,7,12].However, systemic administration of polyamine antagonists, in contrast to MK-801 and memantine, is low effective during electric shock-induced or audiogenic seizures, which do not depend on BBB permeability [5,6]. Since polyamine antagonists after peripheral administration decrease BBB permeability [4,9], it can be expected that intraperitoneal injection of arcaine would reduce the severity of seizures induced by intraperitoneal injection of NMDA due to a decrease in BBB permeability for NMDA, but will not modulate the severity of seizures induced by intracerebral administration of NMDA not depending on BBB permeability.…”